The criteria that Doctors without Borders (Medecins Sans Frontieres, or MSF) use in triaging West Africa Ebola patients resulted in more than a third of patients falsely testing positive, and the guidance needs to be revised, a study yesterday in Eurosurveillance concluded.
Arizona residents are experiencing the first known outbreak of concurrent West Nile virus (WNV) and St. Louis encephalitis virus (SLEV) infections in the United States, and most cases involve neurologic disease, the Centers for Disease Control and Prevention (CDC) reported today in Morbidity and Mortality Weekly Report (MMWR).
The US Centers for Disease Control and Prevention (CDC) yesterday stepped down its travel warnings for both Sierra Leone and Liberia, with Ebola activity continuing at zero weekly cases in both countries.
Liberia was declared free of the disease for a second time on Sep 3, and Sierra Leone will reach that mark on Nov 7 if no new cases are detected before then.
Arbovirus cases, including WNV, were down a bit in 2014, but the diseases had a broad impact.
A large study in Bangladesh of oral killed whole-cell cholera vaccine found that it cut disease rates in half, even with moderate coverage, according to a report yesterday in The Lancet.
Poll: Parents' views on childhood vaccines improvingOne third of US parents polled said they see childhood vaccines as being more beneficial than they did a year ago, and one fourth said they view them as safer, according to a new poll from the University of Michigan.
The ongoing outbreak of cholera in Haiti that began in late 2010 has led to a dramatic rise in cases over the past 6 months, with nearly 12,000 reported already this year. The rate is only expected to soar further when the rainy season starts next month and as international aid dries up, according to an Agence France-Presse (AFP) story yesterday.
Saudi Arabia's Ministry of Health (MOH) reported two new MERS-CoV cases today, bringing the country's total to 821 cases.
For the second time in as many days, Saudi Arabia has reported a new MERS-CoV (Middle East respiratory syndrome coronavirus) case after a month-long hiatus, its Ministry of Health (MOH) said today.
Phase 3 clinical trial results for the most advanced dengue vaccine in development, known as CYD-TDV and made by Sanofi Pasteur, showed it is more than 50% protective overall and nearly 90% effective against the most serious, hemorrhagic form of the disease, according to a new study published in The Lancet.
